文献速递基础与转化研究新药、器械与细胞基因治疗研发

皮下脂肪组织中的施万细胞具有神经发生潜能并可用于再生治疗

Schwann cells in the subcutaneous adipose tissue have neurogenic potential and can be used for regenerative therapies.
PubMed 文献 · Sci Transl Med · 2022-05-25

研究在小鼠和人皮下脂肪组织(SAT)的神经纤维束(NFB)中发现施万细胞,体外培养后去分化形成神经球并获得神经干细胞样特性,命名为SAT-NSCs。SAT-NSCs移植小鼠胃肠道后定植、迁移并分化为神经元和胶质细胞,改善结肠无神经节症和胃轻瘫相关功能缺陷。

要点

  • 小鼠和人SAT的NFB中存在施万细胞,体外培养可去分化形成具有神经发生潜能的SAT-NSCs。
  • SAT-NSCs移植小鼠胃肠道后定植、纵向和环形迁移,分化为神经元和胶质细胞。
  • SAT-NSCs改善结肠无神经节症和胃轻瘫相关功能缺陷,提示胃肠道动力障碍细胞治疗潜力。

核心结论

  • SAT-NSCs来源于NFB内的施万细胞而非间充质干细胞,具有神经发生潜能,并在小鼠模型中改善胃肠道动力障碍相关功能缺陷。

研究设计与样本

  • 研究从小鼠和人皮下脂肪组织(SAT)中获取含施万细胞的神经纤维束(NFB)并进行体外培养。
  • 通过转录组分析、细胞标志物和分化潜能比较,将培养获得的细胞命名为SAT-NSCs。
  • 将SAT-NSCs移植到小鼠胃肠道,评估定植、迁移、分化和功能 rescue。

主要发现

  • 体外培养的SAT来源施万细胞重塑NFB形成神经球,并表现神经发生分化潜能。
  • 转录组分析表明SAT-NSCs获得神经干细胞特性可归因于培养施万细胞的去分化过程。
  • SAT-NSCs与体内内源性施万细胞在基因表达谱、细胞标志物和分化潜能上明显不同。
  • SAT-NSCs移植小鼠胃肠道后定植于肌层,纵向和环形迁移,分化为神经元和胶质细胞,并表现与肠神经元表型一致的神经化学编码和钙信号特性。
  • SAT-NSCs rescue了结肠无神经节症和胃轻瘫相关的功能缺陷。

临床怎么用

  • SAT易于获取,为从成人组织衍生自体神经干细胞提供了前所未有的可及性。
  • 作者认为SAT-NSCs对胃肠道动力障碍具有治疗应用潜力。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stem cell therapies for nervous system disorders are hindered by a lack of accessible autologous sources of neural stem cells (NSCs). In this study, neural crest-derived Schwann cells are found to populate nerve fiber bundles (NFBs) residing in mouse and human subcutaneous adipose tissue (SAT). NFBs containing Schwann cells were harvested from mouse and human SAT and cultured in vitro. During in vitro culture, SAT-derived Schwann cells remodeled NFBs to form neurospheres and exhibited neurogenic differentiation potential. Transcriptional profiling determined that the acquisition of these NSC properties can be attributed to dedifferentiation processes in cultured Schwann cells. The emerging population of cells were termed SAT-NSCs because of their considerably distinct gene expression profile, cell markers, and differentiation potential compared to endogenous Schwann cells existing in vivo. SAT-NSCs successfully engrafted to the gastrointestinal tract of mice, migrated longitudinally and circumferentially within the muscularis, differentiated into neurons and glia, and exhibited neurochemical coding and calcium signaling properties consistent with an enteric neuronal phenotype. These cells rescued functional deficits associated with colonic aganglionosis and gastroparesis, indicating their therapeutic potential as a cell therapy for gastrointestinal dysmotility. SAT can be harvested easily and offers unprecedented accessibility for the derivation of autologous NSCs from adult tissues. Evidence from this study indicates that SAT-NSCs are not derived from mesenchymal stem cells and instead originate from Schwann cells within NFBs. Our data describe efficient isolation procedures for mouse and human SAT-NSCs and suggest that these cells have potential for therapeutic applications in gastrointestinal motility disorders.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Stavely R, Hotta R, Picard N, et al. Schwann cells in the subcutaneous adipose tissue have neurogenic potential and can be used for regenerative therapies. Sci Transl Med. 2022. PMID: 35613280. doi:10.1126/scitranslmed.abl8753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。